The dimerization of RAF kinase not only plays a critical role in the activation of the RAF/MEK/ERK kinase cascade [9–17], but also contributes to drug resistance in cancer therapy [11, 12, 14, 26]. This evidence concerns the gene MAP2K7 and cancer.